ZBTB8A expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.95499172406244E-12 |
Normal-vs-Stage2 |
2.33139999972209E-07 |
Normal-vs-Stage3 |
2.77555756156289E-15 |
Normal-vs-Stage4 |
1.21219700943698E-11 |
Stage1-vs-Stage2 |
5.627400E-01 |
Stage1-vs-Stage3 |
3.999900E-04 |
Stage1-vs-Stage4 |
1.438380E-01 |
Stage2-vs-Stage3 |
1.985610E-01 |
Stage2-vs-Stage4 |
6.771600E-01 |
Stage3-vs-Stage4 |
2.244200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.6242562850266E-12 |
Normal-vs-AfricanAmerican |
2.0173000003787E-07 |
Normal-vs-Asian |
5.692600E-01 |
Caucasian-vs-AfricanAmerican |
4.462000E-01 |
Caucasian-vs-Asian |
1.327030E-01 |
AfricanAmerican-vs-Asian |
6.736100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.10462807976364E-15 |
Normal-vs-Female |
3.24607007939903E-12 |
Male-vs-Female |
7.272200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.446500E-04 |
Normal-vs-Age(41-60Yrs) |
1.69090297319485E-11 |
Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
Normal-vs-Age(81-100Yrs) |
2.3466999998778E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.697000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.150100E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.871600E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.183800E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.028620E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.998400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.793240E-01 |
Normal-vs-Grade 2 |
1.05080000256663E-09 |
Normal-vs-Grade 3 |
9.99200722162641E-16 |
Normal-vs-Grade 4 |
1.27330368471235E-11 |
Grade 1-vs-Grade 2 |
1.117640E-01 |
Grade 1-vs-Grade 3 |
1.804100E-02 |
Grade 1-vs-Grade 4 |
7.897200E-03 |
Grade 2-vs-Grade 3 |
1.94718999999566E-05 |
Grade 2-vs-Grade 4 |
3.886000E-02 |
Grade 3-vs-Grade 4 |
2.843600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.87680990140871E-12 |
Normal-vs-ccB subtype |
6.62170318577182E-12 |
ccA subtype-vs-ccB subtype |
4.327400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62581059726108E-12 |
Normal-vs-N1 |
9.87029999954814E-07 |
N0-vs-N1 |
9.368200E-01 |
|
|